BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7234027)

  • 1. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
    Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
    Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
    Halliday WJ; Maluish AE; Stephenson PM; Davis NC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
    Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF
    Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological reactivity to soluble tumour extracts (STE) in gastrointestinal tumours and related risk groups.
    Storch H; Raabe F; Krahl R; Liebe S; Hambsch K; Fischer H
    Arch Geschwulstforsch; 1982; 52(1):57-61. PubMed ID: 7082132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer.
    Ayeni AO; Thomson DM; MacFarlane JK; Daly D
    Cancer; 1981 Oct; 48(8):1855-62. PubMed ID: 7026024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.
    Tank B; Marquet RL; Vennemans E; Westbroek DL
    J Cancer Res Clin Oncol; 1986; 112(3):276-80. PubMed ID: 3782265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
    Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
    Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of leucocyte adherence inhibition microassay using colorectal cancer cell lines.
    Machida S; Yamauchi M; Sato M; Ishioka T; Takashima K; Nishikawa T; Fukushima M; Koie H
    Gan; 1980 Jun; 71(3):387-92. PubMed ID: 6998824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.